{{Rsnum
|rsid=11739135
|Gene=IBD5
|Chromosome=5
|position=132397705
|Orientation=plus
|GMAF=0.1832
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;G)
| geno3=(G;G)
| CEU | 8.0 | 59.8 | 32.1
| HCB | 0.0 | 0.7 | 99.3
| JPT | 0.0 | 0.9 | 99.1
| YRI | 0.0 | 0.7 | 99.3
| ASW | 0.0 | 22.8 | 77.2
| CHB | 0.0 | 0.7 | 99.3
| CHD | 0.0 | 2.8 | 97.2
| GIH | 1.0 | 17.8 | 81.2
| LWK | 0.0 | 4.5 | 95.5
| MEX | 6.9 | 39.7 | 53.4
| MKK | 0.0 | 5.8 | 94.2
| TSI | 13.7 | 45.1 | 41.2
| HapMapRevision=28
}}

[[rs11739135]] is reported to confer susceptibility to [[Crohn's disease]]. {{PMID|11586304}}

{{PMID Auto
|PMID=19581171
|Title=Identification of Las2, a major modifier gene affecting the Pas1 mouse lung tumor susceptibility locus
}}

{{PMID Auto
|PMID=16519819
|Title=Analysis of polymorphisms in 16 genes in type 1 diabetes that have been associated with other immune-mediated diseases.
|OA=1
}}

{{PMID Auto
|PMID=18650832
|Title=MAST3: a novel IBD risk factor that modulates TLR4 signaling.
|OA=1
}}

{{PMID Auto
|PMID=19214536
|Title=IGR2096a_1 T and IGR2198a_1 C alleles on IBD5 locus of chromosome 5q31 region confer risk for Crohn's disease in Hungarian patients.
}}

{{PMID Auto
|PMID=20066736
|Title=Interaction of the major inflammatory bowel disease susceptibility alleles in Crohn's disease patients.
|OA=1
}}

{{PMID Auto
|PMID=24415875
|Title=Susceptibility to ulcerative colitis in Hungarian patients determined by gene-gene interactions
|OA=1
}}

{{PMID Auto
|PMID=22908971
|Title=Association between inflammatory bowel disease gene 5 (IBD5) and interleukin-23 receptor (IL23R) genetic polymorphisms in Malaysian patients with Crohn's disease.
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}